Article

Efficacy and Safety of Add-On Omalizumab in 4-6-Year-Old Children with Uncontrolled Allergic Asthma: A 52-Week Retrospective Study

2026-02-02

Abstract excerpt

<h4>Background: </h4> Allergic asthma is a common chronic inflammatory disease and the most prevalent asthma phenotype in children. Up to 80% of childhood asthma cases may have an allergic component. Preschool children aged 4–6 years represent a particularly vulnerable group due to ongoing immune and airway development. Although inhaled corticosteroids (ICS) are first‑line therapy, a subset of children remains ina...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d4769180-a019-5617-849e-3c41c503d466
DOI: 10.22541/au.177004814.40417738/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Efficacy and Safety of Add-On Omalizumab in 4-6-Year-Old Children with Uncontrolled Allergic Asthma: A 52-Week Retrospective StudyDOI 10.22541/au.177004814.40417738/v1Read

Influence of effective omalizumab treatment on eosinophils in allergic asthma with comorbiditiesSemantic proximity Read

Clinical Experience with Anti-IgE Monoclonal Antibody (Omalizumab) In Paediatric Severe Allergic Asthma – A Romanian PerspectiveSemantic proximity Read

The efficacy of omalizumab treatment in patients with non-atopic severe asthmaSemantic proximity Read

Biomarkers for severe allergic asthma in children: could they be useful to guide disease control and use of omalizumab?Semantic proximity Read

Japanese guidelines for childhood asthma 2017.Semantic proximity Read

Successful Treatment of Pediatric Systemic Mastocytosis With Omalizumab: Case Report and Literature ReviewSemantic proximity Read

Advances in mechanisms of asthma, allergy, and immunology in 2008.Semantic proximity Read

Omalizumab for the Treatment of Allergic Rhinitis: A Systematic Review and Meta-AnalysisSemantic proximity Read

Update on the Treatment of Allergic Rhinitis in ChildrenSemantic proximity Read

Influence of Genetics on the Response to Omalizumab in Patients with Severe Uncontrolled Asthma with an Allergic Phenotype.Semantic proximity Read

Clinical characteristics and biological treatment responses of patients with late-onset asthma phenotype.Semantic proximity Read

Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives.Semantic proximity Read